Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)

Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund’s holding of the stock. As reported in a recent filing with the Securities and Exchange Commission, Dubois’ fund, Camber Capital Management, now holds 1.72 million shares, up from the 750,000 shares reported in its latest 13F filing. As a result, Camber and Dubois now have control over 5.52% of the Genomic Health’s common stock.

Genomic Health, Inc. (NASDAQ:GHDX)

Genomic Health, Inc. (NASDAQ:GHDX) has also attracted the attention of Ken Griffin and Israel Englander. During the first quarter of this year, Griffin’s Citadel Investment Group increased its holding of the stock by 28% to approximately 206,400 shares. Englander has also boosted his fund’s stake by 35%, taking it to 370,000 shares. Julian Baker and Felix Baker are also keeping tabs, with their fund, Baker Bros. Advisors, reporting ownership of 13.6 million shares in its latest 13F filing.

A provider of genomic-based clinical laboratory services, Genomic Health, Inc. (NASDAQ:GHDX) has seen its stock depreciate by 4% so far this year to a current price of $28.07 per share, which gives the company a market cap of $876 million. For the three months ending March 31, 2014, Genomic Health has reported revenues of $67 million, a year-over-year increase of 6.2% and a loss per share of $0.24. For the second quarter analysts estimate a loss of $0.26 per share and $69 million in revenues.

Dubois is also betting on Sequenom Inc. (NASDAQ:SQNM), having recently increased his fund’s stake to 6.30 million shares or 5.41% of the total number of shares outstanding. Another company Dubois sees value in is Cardica, Inc. (NASDAQ:CRDC). Camber Capital has reported a new position at the end of April, amassing 8.37 million shares, which account for approximately 10% of the common stock. The biggest equity position in Camber’s portfolio continues to be Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), although Dubois has decreased it by 18% during the first quarter of 2014 to 1.65 million shares.

Disclosure: none.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!